We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Electron Microscope Specialists Join Interaction Proteome

By Biotechdaily staff writers
Posted on 04 May 2004
A new research partnership has been announced within the framework of Interaction Proteome, the European Commission's five-year and 12 million euro project to propel Europe into a leadership role in the field of functional proteomics.

The latest addition to the project is FEI (Eindhoven, The Netherlands), specialists in the development and manufacture of electron microscopes and other charged-particle beam systems. More...
FEI will collaborate directly with the Max Planck Institute of Biochemistry (Martinsried, Germany) a leading laboratory in electron tomography. This collaboration is intended to stimulate the development of a new generation of instruments with improved sensitivity suited to the analysis of protein complexes within the cell.

"We are excited and honored to participate in this project. New technologies, testing systems, and approaches will be required to process the explosion of data expected to come out of this field,” said Dr. Werner Hax, life sciences product manager for FEI's electron optics division. "Participation in the Interaction Proteome consortium underscores FEI's commitment to providing customers with important life-science technologies.”




Related Links:
FEI
Max Planck Institute of Biochemistry

Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
New
Gold Member
Neonatal Heel Incision Device
Tenderfoot
New
CMV CLIA Diagnostic
CLIA CMV IgA Screen Group
New
HPV Test
Allplex HPV28 Detection
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image

Urine-Based Multi-Cancer Screening Test Receives FDA Breakthrough Device Designation

Early detection across multiple cancers remains a major unmet need in population screening. Non-invasive approaches that can be delivered at scale may broaden access and shift diagnoses to earlier stages.... Read more

Molecular Diagnostics

view channel
Image: The new approach focuses on CpG DNA methylation, a chemical modification of cytosine and guanine bases, using tumor samples to develop a computational model that distinguishes among 21 cancer types (photo credet: 123RF)

Machine Learning Model Uses DNA Methylation to Predict Tumor Origin in Cancers of Unknown Primary

Cancers of unknown primary (CUP) are metastatic malignancies in which the primary site cannot be identified, complicating treatment selection. Many patients consequently receive broad, nonspecific chemotherapy... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.